Global health nonprofits invest over $100M to fast-track vaccines for the rare Bundibugyo Ebola strain. Three candidates from IAVI, Oxford, and Moderna target the outbreak in DRC and Uganda, though clinical trials face challenges from conflict and misinformation.
Global health groups pledge $100M for rare Ebola vaccine
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →